Healthcare provider profile · identity verified

Emil Fernando, MD

Internal Medicine · POPLAR BLUFF, MO · NPI 1982968129

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	424	130
Amlodipine Besylate	Amlodipine Besylate	388	120
Losartan Potassium	Losartan Potassium	296	93
Metoprolol Succinate	Metoprolol Succinate	287	83
Lisinopril	Lisinopril	277	86
Omeprazole	Omeprazole	276	76
Hydrochlorothiazide	Hydrochlorothiazide	223	67
Gabapentin	Gabapentin	218	77
Levothyroxine Sodium	Levothyroxine Sodium	207	57
Furosemide	Furosemide	186	63
Metformin Hcl	Metformin Hcl	185	58
Sertraline Hcl	Sertraline Hcl	155	46
Metoprolol Tartrate	Metoprolol Tartrate	154	48
Tamsulosin Hcl	Tamsulosin Hcl	153	54
Pantoprazole Sodium	Pantoprazole Sodium	152	52
Eliquis	Apixaban	137	38
Tramadol Hcl	Tramadol Hcl	127	46
Mirtazapine	Mirtazapine	116	37
Simvastatin	Simvastatin	106	34
Clopidogrel	Clopidogrel Bisulfate	96	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	96	25
Pravastatin Sodium	Pravastatin Sodium	95	29
Warfarin Sodium	Warfarin Sodium	93	20
Duloxetine Hcl	Duloxetine Hcl	92	26
Ciprofloxacin Hcl	Ciprofloxacin Hcl	90	69
Rosuvastatin Calcium	Rosuvastatin Calcium	87	21
Trazodone Hcl	Trazodone Hcl	85	23
Carvedilol	Carvedilol	84	30
Donepezil Hcl	Donepezil Hcl	84	20
Spironolactone	Spironolactone	83	27
Lovastatin	Lovastatin	82	26
Allopurinol	Allopurinol	79	21
Glimepiride	Glimepiride	78	23
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	77	21
Memantine Hcl	Memantine Hcl	74	15
Azithromycin	Azithromycin	73	66
Alprazolam	Alprazolam	71	31
Albuterol Sulfate Hfa	Albuterol Sulfate	66	32
Alendronate Sodium	Alendronate Sodium	59	17
Fluticasone Propionate	Fluticasone Propionate	59	34
Potassium Chloride	Potassium Chloride	59	16
Oxybutynin Chloride Er	Oxybutynin Chloride	58	13
Finasteride	Finasteride	57	17
Quetiapine Fumarate	Quetiapine Fumarate	54	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	52	42
Famotidine	Famotidine	50	17
Ezetimibe	Ezetimibe	48	18
Escitalopram Oxalate	Escitalopram Oxalate	46	15
Meloxicam	Meloxicam	46	17
Paroxetine Hcl	Paroxetine Hcl	44	12
Triamcinolone Acetonide	Triamcinolone Acetonide	43	28
Xarelto	Rivaroxaban	41	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	39	11
Prednisone	Prednisone	38	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Ramipril	Ramipril	37	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	21
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Glipizide Er	Glipizide	34	suppressed
Montelukast Sodium	Montelukast Sodium	33	12
Bupropion Xl	Bupropion Hcl	32	16
Doxycycline Hyclate	Doxycycline Hyclate	32	25
Hydroxyzine Hcl	Hydroxyzine Hcl	32	19
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Methylprednisolone	Methylprednisolone	31	29
Torsemide	Torsemide	31	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Atenolol	Atenolol	30	11
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Naproxen	Naproxen	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	12
Myrbetriq	Mirabegron	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Midodrine Hcl	Midodrine Hcl	23	12
Terazosin Hcl	Terazosin Hcl	23	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	22	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	18
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Folic Acid	Folic Acid	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Temazepam	Temazepam	19	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	12
Lorazepam	Lorazepam	17	suppressed
Nystatin	Nystatin	17	14
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Cefdinir	Cefdinir	15	13
Estradiol	Estradiol	15	suppressed
Glipizide	Glipizide	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	15
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Topiramate	Topiramate	15	suppressed
Benzonatate	Benzonatate	14	13
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	12
Ozempic	Semaglutide	14	suppressed
Phenytoin	Phenytoin	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Mirabegron Er	Mirabegron	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Digoxin	Digoxin	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nadolol	Nadolol	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Prolia	Denosumab	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error